Study Information
Status: Active, Recruiting
Study Details
View study details on clinicaltrials.gov.
Locations
East Bay, San Francisco, Greater Sacramento Valley, Palo Alto/Santa Cruz, San Mateo, Santa Rosa, Solano/Vallejo, Modesto
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Randomized Phase II/III Study of Nivolumab Plus Ipilimumab Plus Sargramostim Versus Nivolumab Plus Ipilimumab in Patients With Unresectable Stage III or Stage IV Melanoma